Stock Events

Stock Events

Cartesian Therapeutics (RNAC) Q4 2025 Earnings

6NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-1.38

-0.75

-0.13

0.5

Details

Expected EPS

-0.847067

Actual EPS

-1.38

Surprise EPS

-0.53

Surprise Percent

+62.92%

Description

Cartesian Therapeutics (RNAC) has reported earnings of -1.38 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.